PSA Today Oct 25: Nidec, Canon post results/DoCoMo Nikkei preview/Chugai 3Q beats CE and Consensus/Sprint/Fanuc's blow-out numbers - Nikkei -0.45%
Japan Market Comment by Pelham Smithers and William Nestuk
Nikkei ¥21,707.62 (-¥97.55 / -0.45%); Topix ¥1,751.43 (-¥5.49 / -0.31%); ¥/$113.52
Tags: Shionogi (4507), Nidec (6594), Canon (7751), DoCoMo (9437), Advantest (6857), Chugai Pharmaceutical (4519), Sprint (S US), T-Mobile (TMUS US), SoftBank (9984), Fanuc (6954), Yaskawa (6506)
- Nikkei rally ends despite strong opening as profit taking emerges
- Nidec down, Canon up following strong results
- Nikkei previews NTT DoCoMo 1H
- Chugai Pharma’s FY17 3Q OP beats guidance and consensus
- Sprint – no earnings call tonight
- Fanuc’s after hours blow-out numbers
Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods.
PSA produces both company and sector reports. The focus of PSA’s research is to identify winners and losers as new technologies impact the top and bottom lines of corporations. Critical to our research is the clear explanation of how these new technologies work and how they impact companies and industries.
The founding partners have worked closely together for twenty years and the team has more than doubled in size since 2012.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.